Global Primary Immunodeficiency Disorders Market Size & Outlook
Global primary immunodeficiency disorders market, 2018-2030 (US$M)
Related Markets
Global primary immunodeficiency disorders market highlights
- The global primary immunodeficiency disorders market generated a revenue of USD 7,150.4 million in 2023 and is expected to reach USD 11,142.2 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 6.5% by 2030.
- In terms of segment, immunoglobulin replacement therapy accounted for a revenue of USD 7,150.4 million in 2023.
- Immunoglobulin Replacement Therapy is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
Global data book summary
| Market revenue in 2023 | USD 7,150.4 million |
| Market revenue in 2030 | USD 11,142.2 million |
| Growth rate | 6.5% (CAGR from 2023 to 2030) |
| Largest segment | Immunoglobulin replacement therapy |
| Fastest growing segment | Immunoglobulin Replacement Therapy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunoglobulin Replacement Therapy |
Other key industry trends
- In terms of revenue, the North America accounted for 45.4% of the global primary immunodeficiency disorders market in 2023.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Primary Immunodeficiency Disorders Market Scope
Primary Immunodeficiency Disorders Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global primary immunodeficiency disorders market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to primary immunodeficiency disorders market will help companies and investors design strategic landscapes.
Immunoglobulin replacement therapy was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Global primary immunodeficiency disorders market based on immunoglobulin replacement therapy covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Primary Immunodeficiency Disorders Product Outlook (Revenue, USD Million, 2018-2030)
- Immunoglobulin Replacement Therapy
- Stem Cell/Bone Marrow Transplantation
- Antibiotic Therapy
- Gene Therapy
- Others
- Global Primary Immunodeficiency Disorders Disease Outlook (Revenue, USD Million, 2018-2030)
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
Reasons to subscribe to Global primary immunodeficiency disorders market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global primary immunodeficiency disorders market databook
-
Our clientele includes a mix of primary immunodeficiency disorders market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global primary immunodeficiency disorders market , including forecasts for subscribers. This global databook contains high-level insights into Global primary immunodeficiency disorders market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global primary immunodeficiency disorders market size, by regions, 2018-2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
